Company was incorporated as ‘MedPlus Health Services Private Limited’ at Hyderabad Andhra Pradesh as a private limited company under the Companies Act 1956 and was granted the certificate of incorporation on November 30 2006 by the Registrar of Companies Andhra Pradesh at Hyderabad. Our Company was converted from a private limited company to a public limited company pursuant to a special resolution passed by our Shareholders at the EGM held on June 1 2021 and the name of our Company was changed to ‘MedPlus Health Services Limited’. Consequently a fresh certificate of incorporation was issued by the Registrar of Companies Telangana at Hyderabad on June 28 2021.Major events2007Pharmaceutica Ventures Limited invested ?800 million by subscribing to 45720 equity shares Peepul Capital Fund II LLC invested ? 226.33 million by subscribing to 30000 equity shares of the Company and NEA-IndoUS Venture Capital LLC invested $5 million by subscribing to 11620 equity shares of our Company (out of which 4662 equity shares through conversion of Series A CCPS.)2012EBITDA of our Company turned positive2017Gangadi Investments Private Limited acquired 122347 equity shares 12000000 unlisted redeemable preference shares and 42847000 non-convertible debentures from MKCP Direct Investments (Mauritius) IV Limited MKCP Institutional Investor (Mauritius) III Limited TVS Shriram Growth Fund IA and Indiaventure Trust – Fund I2019PI Opportunities Fund - I invested acquiring 22.21% stake of our Company as on date pursuant to purchase of 21233 equity shares2021Lavender Rose invested ?6.56 billion acquiring a 24.58% stake of our Company as on date through primary and secondary transactions.PI Opportunities Fund - I invested ?222.10 million by subscribing to 160147 Series C2 CCPS
Name | Position |
---|---|
Mr. Gangadi Madhukar Reddy | Chairman & M.D & CEO |
Dr. Cherukupalli Bhaskar Reddy | Whole Time Director & COO |
Mr. Anish Kumar Saraf | Non Executive Director |
Mr. Madhavan Ganesan | Ind. Non-Executive Director |
Mr. Murali Sivaraman | Ind. Non-Executive Director |